The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / New Study Examines Cerebrovascular Events in Lupus Patients

New Study Examines Cerebrovascular Events in Lupus Patients

May 17, 2019 • By Linda Childers

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Improving Prognosis & Treatment

Previous studies have found patients with SLE are at a higher risk of stroke than the general population, regardless of the type of stroke, and that the relative risk is greater in younger patients.2 These studies show most cases of stroke occurred in the first five years of the disease, particularly during the first year, emphasizing the importance of screening for modifiable risk factors to guide prevention strategies at the time of diagnosis of SLE.

You Might Also Like
  • New Study Examines Pregnancy Risk Factors for Patients with Lupus
  • Pinpoint Cognitive Dysfunction in Patients with Lupus
  • Study Reveals Lupus Is a Leading Cause of Death in U.S. Women
Explore This Issue
May 2019
Also By This Author
  • How to Maintain Connections with Colleagues, Staff & Patients During a Pandemic: A Q&A with Reshma Khan, MD

Increasing awareness of the risk of stroke in patients with SLE may help prevent strokes & minimize disability, if the risk is identified early.

Dr. Hanly notes that increasing awareness of the risk of stroke in patients with SLE may help prevent strokes and minimize disability, if the risk is identified early. He recommends screening all patients diagnosed with SLE for traditional cerebro­vascular events at the time of diagnosis and annually thereafter.

Dr. Hanly also notes stroke rates are higher in SLE patients of African ancestry. Another recent study, published in Seminars in Arthritis & Rheumatism, showed that certain races were disproportionately affected by cerebrovascular events.3 The study found that black SLE patients in the U.S. are at a 34% higher risk of stroke than white patients, while Hispanics had a 25% greater risk.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The study, conducted by researchers in Boston and New York, identified 65,788 SLE patients between the ages of 18 and 65 and found that after conducting a mean follow-up of 3.7 years, 1,441 first-stroke events were recorded (1,208 ischemic and 233 hemorrhagic). In conducting their analysis, researchers took into account such risk factors as hypertension, heart failure and cardiovascular disease, as well as medication use and sociodemographic factors.

Although the mortality rate for SLE has improved over the past three decades, Dr. Hanly says the mortality rate for lupus patients remains high relative to non-lupus populations.

According to the Centers for Disease Control and Prevention, SLE is the 10th leading cause of death in women ages 15–24 and the fifth leading cause of death for black and Latina women in that cohort.4

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“We have one approved biologic currently being used to treat SLE, [and] a number of investigational drugs [are] being tested in clinical trials,” Dr. Hanly says.

As for current treatment guidelines, Dr. Hanly notes that, due to the potential side effects, there isn’t enough evidence to recommend putting all SLE patients at high risk on anticoagulants.

“There are other, safer lifestyle measures that can reduce the risk of stroke, including maintaining a healthy body weight, reducing hypertension, quitting smoking, engaging in regular daily exercise and keeping high cholesterol and diabetes in check,” Dr. Hanly says. “Future studies [may] provide new insights and information that can be used in developing individualized treatment plans.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: hemorrhagic stroke, ischemic stroke, strokeIssue: May 2019

You Might Also Like:
  • New Study Examines Pregnancy Risk Factors for Patients with Lupus
  • Pinpoint Cognitive Dysfunction in Patients with Lupus
  • Study Reveals Lupus Is a Leading Cause of Death in U.S. Women
  • New Study Examines Treatment Options for Incomplete Lupus Erythematous

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)